Johnson & Johnson will review growth strategies for its Pharmaceuticals business and address therapeutic area strategy, advancing key compounds in its pipeline, and leveraging global market strategies to grow market share and expand geographic presence. J&J plans to continue to address and build on five therapeutic areas: neuroscience, cardiovascular and metabolism, immunology, oncology and infectious diseases/vaccines. “Our people focus every day on addressing the world’s...